-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$20.3329.08% Upside
IGM Biosciences, Inc. Frequently Asked Questions
-
What analysts cover IGM Biosciences, Inc.?
IGM Biosciences, Inc. has been rated by research analysts at RBC Capital, Stifel Nicolaus, Truist Financial, Wedbush, Morgan Stanley, Robert W. Baird in the past 90 days.